Association Between Use of Proton Pump Inhibitors and a Clostridium difficile– Associated Disease Outbreak: Case–Control Study

This publication has 18 references indexed in Scilit:

• Health Care–AssociatedClostridium difficileInfection in Adults Admitted to Acute Care Hospitals in Canada: A Canadian Nosocomial Infection Surveillance Program Study
  Clinical Infectious Diseases, 2009
• Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy
  CMAJ : Canadian Medical Association Journal, 2006
• Use of Gastric Acid–Suppressive Agents and the Risk of Community-Acquired Clostridium difficile–Associated Disease
  JAMA, 2005
• Emergence of Fluoroquinolones as the Predominant Risk Factor for Clostridium difficile-Associated Diarrhea: A Cohort Study during an Epidemic in Quebec
  Clinical Infectious Diseases, 2005
• Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies
  CMAJ : Canadian Medical Association Journal, 2004
• Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea
  Journal of Hospital Infection, 2003
• Outbreak of Clostridium difficile -related diarrhoea in an adult oncology unit: risk factors and microbiological characteristics
  Journal of Hospital Infection, 2003
• Gastric acid suppression does not promote clostridial diarrhoea in the elderly.
  QJM: An International Journal of Medicine, 2000
• Risk factors for Clostridium difficile infection
  Journal of Hospital Infection, 1998
• Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study.
  Gut, 1996